Profil

DEVAUX Yvan

University of Luxembourg

Main Referenced Co-authors
ACHARYA, Shubhra  (6)
Lumley, Andrew I (3)
Martelli, Fabio (3)
Barbalata, Teodora (2)
Emanueli, Costanza (2)
Main Referenced Keywords
Cardiology and Cardiovascular Medicine (2); Humans (2); Parkinson Disease (2); Parkinson Disease/genetics (2); RNA (2);
Main Referenced Unit & Research Centers
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group) (1)
Main Referenced Disciplines
Biochemistry, biophysics & molecular biology (5)
Cardiovascular & respiratory systems (2)
Neurology (1)
Life sciences: Multidisciplinary, general & others (1)
Education & instruction (1)

Publications (total 8)

The most downloaded
77 downloads
Badimon, L., Robinson, E. L., Jusic, A., Carpusca, I., deWindt, L. J., Emanueli, C., Ferdinandy, P., Gu, W., Gyöngyösi, M., Hackl, M., Karaduzovic-Hadziabdic, K., Lustrek, M., Martelli, F., Nham, E., Potočnjak, I., Satagopam, V., Schneider, R., Thum, T., Devaux, Y., & CA17129, O. B. O. E. U.-C. C. A. (2021). Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovascular Research. doi:10.1093/cvr/cvab094 https://hdl.handle.net/10993/47605

The most cited

15 citations (WOS)

Badimon, L., Robinson, E. L., Jusic, A., Carpusca, I., deWindt, L. J., Emanueli, C., Ferdinandy, P., Gu, W., Gyöngyösi, M., Hackl, M., Karaduzovic-Hadziabdic, K., Lustrek, M., Martelli, F., Nham, E., Potočnjak, I., Satagopam, V., Schneider, R., Thum, T., Devaux, Y., & CA17129, O. B. O. E. U.-C. C. A. (2021). Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovascular Research. doi:10.1093/cvr/cvab094 https://hdl.handle.net/10993/47605

Karagianni, K., Bibi, A., Madé, A., ACHARYA, S., Parkkonen, M., Barbalata, T., Srivastava, P. K., de Gonzalo-Calvo, D., Emanueli, C., Martelli, F., DEVAUX, Y., Dafou, D., Nossent, A. Y., & EU-CardioRNA COST Action CA17129. (12 March 2024). Recommendations for detection, validation, and evaluation of RNA editing events in cardiovascular and neurological/neurodegenerative diseases. Molecular Therapy: Nucleic Acids, 35 (1), 102085. doi:10.1016/j.omtn.2023.102085
Peer Reviewed verified by ORBi

ACHARYA, S., Das, S., DEVAUX, Y., & Robinson, E. L. (2023). The impact of government policies, funding, and networking to accelerate transatlantic cardiovascular research. European Heart Journal. doi:10.1093/eurheartj/ehad818
Peer Reviewed verified by ORBi

ACHARYA, S., Preda, M. B., Papatheodorou, I., Palioura, D., Giardoglou, P., Tsata, V., Erceg, S., Barbalata, T., Ben-Aicha, S., Martino, F., Nicastro, L., Lazou, A., Beis, D., Martelli, F., Sopic, M., Emanueli, C., Kardassis, D., & DEVAUX, Y. (12 October 2023). The science behind soft skills: Do’s and Don’ts for early career researchers and beyond. A review paper from the EU-CardioRNA COST Action CA17129. Open Research Europe, 3, 55. doi:10.12688/openreseurope.15746.2
Peer reviewed

ACHARYA, S., Lumley, A. I., & DEVAUX, Y. (20 June 2023). Targeting regulatory RNAs at the heart of Parkinson's disease. European Heart Journal, 44 (23), 2059 - 2060. doi:10.1093/eurheartj/ehad010
Peer Reviewed verified by ORBi

ACHARYA, S., Lumley, A. I., Zhang, L., Vausort, M., DEVAUX, Y., & On Behalf Of The Ncer-Pd Consortium. (12 June 2023). GATA3 as a Blood-Based RNA Biomarker for Idiopathic Parkinson's Disease. International Journal of Molecular Sciences, 24 (12), 10040. doi:10.3390/ijms241210040
Peer Reviewed verified by ORBi

Vausort, M., Niedolistek, M., Lumley, A. I., Oknińska, M., Paterek, A., Mączewski, M., Dong, X., Jäger, C., Linster, C., Leszek, P., & Devaux, Y. (2022). Regulation of N6-Methyladenosine after Myocardial Infarction. Cells, 11 (15), 2271. doi:10.3390/cells11152271
Peer Reviewed verified by ORBi

ACHARYA, S., Lumley, A. I., & DEVAUX, Y. (October 2021). Non-coding RNAs and stem cells: the dream team for neural regeneration in Parkinson's disease? Neural Regeneration Research, 16 (10), 2017 - 2018. doi:10.4103/1673-5374.308090
Peer Reviewed verified by ORBi

Badimon, L., Robinson, E. L., Jusic, A., Carpusca, I., deWindt, L. J., Emanueli, C., Ferdinandy, P., Gu, W., Gyöngyösi, M., Hackl, M., Karaduzovic-Hadziabdic, K., Lustrek, M., Martelli, F., Nham, E., Potočnjak, I., Satagopam, V., Schneider, R., Thum, T., Devaux, Y., & CA17129, O. B. O. E. U.-C. C. A. (2021). Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129. Cardiovascular Research. doi:10.1093/cvr/cvab094
Peer Reviewed verified by ORBi

Contact ORBilu